Bayer

Bayer CEO plots management cuts as first step in larger overhaul
Bayer CEO plots management cuts as first step in larger overhaul
Fierce Pharma
Bayer
Pharma CEOs
Bill Anderson
layoffs
Flag link:
Bayer Is Rapidly Expanding Its Footprint With Artificial Intelligence
Bayer Is Rapidly Expanding Its Footprint With Artificial Intelligence
ForbesBayer Is Rapidly Expanding Its Footprint With Artificial Intelligence
Bayer
artificial intelligence
Google
Flag link:
Bayer looks to expand Kerendia label to include heart failure
Bayer looks to expand Kerendia label to include heart failure
Clinical Trials Arena
Bayer
Kerendia
clinical trials
heart failure
Flag link:
Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data
Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data
MedCity News
Bayer
cell therapy
Parkinson's Disease
clinical trials
Flag link:
Bayer preps for phase 2 after Parkinson's cell therapy clears safety bar in early-stage study
Bayer preps for phase 2 after Parkinson's cell therapy clears safety bar in early-stage study
Fierce Biotech
Bayer
Parkinson's Disease
cell therapy
bemdaneprocel
BlueRock Therapeutics
Flag link:
Bayer's digital drive in consumer health gathers pace
Bayer's digital drive in consumer health gathers pace
Pharmaphorum
Bayer
consumer health
digital health
Mahana Therapeutics
Flag link:
Bayer pledges $500K in drugs and cash relief to Maui following devastating wildfires
Bayer pledges $500K in drugs and cash relief to Maui following devastating wildfires
Fierce Pharma
Bayer
Hawaii
Maui
wildfires
donations
Flag link:
Bayer-bought BlueRock cuts 12% of workforce across 3 sites as pipeline contracts
Bayer-bought BlueRock cuts 12% of workforce across 3 sites as pipeline contracts
Fierce Biotech
BlueRock Therapeutics
Parkinson's Disease
Bayer
layoffs
Flag link:
With sales in free fall, Bayer's new CEO Anderson considers structural change
With sales in free fall, Bayer's new CEO Anderson considers structural change
Fierce Pharma
Bayer
Pharma CEOs
Bill Anderson
Flag link:
Bayer ends respiratory distress drug development in latest phase 2 cleanout
Bayer ends respiratory distress drug development in latest phase 2 cleanout
Fierce Pharma
Bayer
adrenomedullin pegol
earnings
ARDS
Flag link:
Bayer expects gloomier 2023 as lower glyphosate sales bolster breakup advocates' case
Bayer expects gloomier 2023 as lower glyphosate sales bolster breakup advocates' case
Fierce Pharma
Bayer
earnings
Flag link:
Check out the most-seen pharma brand TV debuts of 2023
Check out the most-seen pharma brand TV debuts of 2023
Medical Marketing and Media
TV ads
DTC advertising
Bayer
AbbVie
Bristol Myers Squibb
Flag link:
Bayer's Parkinson's cell therapy passes early clinical safety test, clearing path to phase 2
Bayer's Parkinson's cell therapy passes early clinical safety test, clearing path to phase 2
Fierce Biotech
Bayer
Parkinson's Disease
clinical trials
cell therapy
bemdaneprocel
Flag link:
Bayer needs 'midsize acquisition' to reach $10B oncology sales goal, exec says
Bayer needs 'midsize acquisition' to reach $10B oncology sales goal, exec says
Fierce Pharma
Bayer
oncology
M&A
Flag link:
Bayer licenses lipid nanoparticle tech for gene therapy
Bayer licenses lipid nanoparticle tech for gene therapy
BioProcess International
Bayer
Acuitas Therapeutics
gene editing
Flag link:
Bayer launches precision health unit in latest digital health venture
Bayer launches precision health unit in latest digital health venture
BioPharma Dive
Bayer
consumer health
digital health
precision health
Flag link:
Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology
Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology
BioSpace
Bayer
Cedilla Therapeutics
CyclinE1/CDK2 inhibitors
oncology
precision oncology
Flag link:
Go or no go? Key FDA decisions for Argenx and Regeneron
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
Flag link:
Bayer's acting BD chief lobbies for the job the only way he knows how: by making deals
Bayer's acting BD chief lobbies for the job the only way he knows how: by making deals
Fierce Biotech
Bayer
business development
Flag link:
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Bayer, Amgen looked at Iveric before agreeing to Astellas sale
Seeking Alpha
Astellas
Iveric Bio
Bayer
Amgen
M&A
Flag link:

Pages